Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/79742
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans |
Author: | Wu, T. Bound, M. Standfield, S. Gedulin, B. Jones, K. Horowitz, M. Rayner, C. |
Citation: | Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 2013; 15(5):474-477 |
Publisher: | Blackwell Publishing Ltd |
Issue Date: | 2013 |
ISSN: | 1462-8902 1463-1326 |
Statement of Responsibility: | T. Wu, M. J. Bound, S. D. Standfield, B.Gedulin, K. L. Jones, M. Horowitz & C. K. Rayner |
Abstract: | Glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), secreted by enteroendocrine L-cells located most densely in the colon and rectum, are of fundamental importance in blood glucose and appetite regulation. In animal models, colonic administration of bile acids can stimulate GLP-1 and PYY by TGR5 receptor activation. We evaluated the effects of taurocholic acid (TCA), administered as an enema, on plasma GLP-1 and PYY, as well as gastrointestinal sensations in 10 healthy male subjects, and observed that rectal administration of TCA promptly stimulated secretion of both GLP-1 and PYY, and increased fullness, in a dose-dependent manner. These observations confirm that topical application of bile acids to the distal gut may have potential for the management of type 2 diabetes and obesity. |
Keywords: | bile salt glucagon-like peptide 1 peptide YY |
Rights: | © 2012 Blackwell Publishing Ltd |
DOI: | 10.1111/dom.12043 |
Appears in Collections: | Aurora harvest Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.